These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31990752)

  • 1. Prolonged activated partial thromboplastin time with no clear explanation.
    Nakav S; Blickstein D; Raanani P; Rabizadeh E; Spectre G
    Blood Coagul Fibrinolysis; 2020 Apr; 31(3):225-228. PubMed ID: 31990752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Rare Cause of Isolated Prolonged Activated Partial Thromboplastin Time: An Overview of Prekallikrein Deficiency and the Contact System.
    Riano I; Prasongdee K
    J Investig Med High Impact Case Rep; 2021; 9():23247096211012187. PubMed ID: 33940978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixing Studies in Patients With Prolonged Activated Partial Thromboplastin Time or Prothrombin Time.
    Benzon HT; Park M; McCarthy RJ; Kendall MC; Lindholm PF
    Anesth Analg; 2019 Jun; 128(6):1089-1096. PubMed ID: 31094773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kaolin-correctable prolongation of the activated partial thromboplastin time.
    Briselli MF; Ellman L
    Am J Clin Pathol; 1980 Nov; 74(5):677-80. PubMed ID: 7446472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Investigation of coagulation time: PT and APTT].
    Ramakers C; van der Heul C; van Wijk EM
    Ned Tijdschr Geneeskd; 2012; 156(0):A3985. PubMed ID: 22917038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulation Testing in the Core Laboratory.
    Winter WE; Flax SD; Harris NS
    Lab Med; 2017 Nov; 48(4):295-313. PubMed ID: 29126301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A Pediatric Case of Acquired Hemophilia A: The Usefulness of the Activated Partial Thromboplastin Time (APTT) Cross-Mixing Test for Early Diagnosis].
    Asai H; Shirayama R; Oshida K; Honda Y; Sato T; Sakai M; Kusuhara K
    J UOEH; 2018; 40(4):331-337. PubMed ID: 30568085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How to Optimize Activated Partial Thromboplastin Time (APTT) Testing: Solutions to Establishing and Verifying Normal Reference Intervals and Assessing APTT Reagents for Sensitivity to Heparin, Lupus Anticoagulant, and Clotting Factors.
    Favaloro EJ; Kershaw G; Mohammed S; Lippi G
    Semin Thromb Hemost; 2019 Feb; 45(1):22-35. PubMed ID: 30630206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Causes of isolated prolonged activated partial thromboplastin time in an acute care general hospital.
    Chng WJ; Sum C; Kuperan P
    Singapore Med J; 2005 Sep; 46(9):450-6. PubMed ID: 16123828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prekallikrein deficiency.
    Quail MT
    J Pediatr Oncol Nurs; 2013; 30(4):198-204. PubMed ID: 23629422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On-site prothrombin time, activated partial thromboplastin time, and platelet count. A comparison between whole blood and laboratory assays with coagulation factor analysis in patients presenting for cardiac surgery.
    Despotis GJ; Santoro SA; Spitznagel E; Kater KM; Barnes P; Cox JL; Lappas DG
    Anesthesiology; 1994 Feb; 80(2):338-51. PubMed ID: 8311316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of prothrombin time and activated partial thromboplastin time mixing studies using an estimated factor correction method.
    Chen J; Phillips B; Chandler WL
    Blood Coagul Fibrinolysis; 2016 Jan; 27(1):90-6. PubMed ID: 26397883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated partial thromboplastin time derivative curves: helpful diagnostic tool in mixing test interpretation.
    Esmedere Eren S; Karakukcu C; Ciraci MZ; Ustundag Y; Karakukcu M
    Blood Coagul Fibrinolysis; 2018 Jun; 29(4):410-414. PubMed ID: 29708898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unexpected, isolated activated partial thromboplastin time prolongation: A practical mini-review.
    Rasmussen KL; Philips M; Tripodi A; Goetze JP
    Eur J Haematol; 2020 Jun; 104(6):519-525. PubMed ID: 32049377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paradoxic effect of multiple mild coagulation factor deficiencies on the prothrombin time and activated partial thromboplastin time.
    Burns ER; Goldberg SN; Wenz B
    Am J Clin Pathol; 1993 Aug; 100(2):94-8. PubMed ID: 8356955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged Partial Thromboplastin Time Without Bleeding History; Fletcher Factor Deficiency.
    Üstün C; Jillella A; Hendriks L; Jonah M; Kutlar F; Burgess R; Kurtlar A
    Turk J Haematol; 2002 Sep; 19(3):417-9. PubMed ID: 27264979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prekallikrein deficiency in a family of miniature horses.
    Turrentine MA; Sculley PW; Green EM; Johnson GS
    Am J Vet Res; 1986 Nov; 47(11):2464-7. PubMed ID: 3641551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Prolonged Activated Partial Thromboplastin Time in a Child With Hodgkin Lymphoma.
    Kara B; Kart KK; Koksal Y
    J Pediatr Hematol Oncol; 2021 Apr; 43(3):e401-e403. PubMed ID: 32000198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The investigation of a prolonged APTT with specific clotting factor assays is unnecessary if an APTT with Actin FS is normal.
    Bowyer A; Smith J; Woolley AM; Kitchen S; Hampton KK; Maclean RM; VAN Veen JJ; Makris M
    Int J Lab Hematol; 2011 Apr; 33(2):212-8. PubMed ID: 20880301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prothrombin time and thromboplastin time. On-site measurement of the prothrombin time and activated partial thromboplastin time of surgical patients with laser photometry].
    Tschaikowsky K; Balint R; Pscheidl E; Bremer F
    Anaesthesist; 1998 Apr; 47(4):295-302. PubMed ID: 9615846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.